Why the study?
Arrhythmogenic right ventricular cardiomyopathy remains rare, and its diagnosis and management in clinical practice are currently far from satisfactory.
Does radiofrequency ablation guided by voltage mapping and right ventriculography prevent ventricular tachycardia in a patient with ARVC?
Does radiofrequency ablation guided by voltage mapping and right ventriculography prevent ventricular tachycardia in a patient with ARVC?
The combined application of voltage mapping and right ventriculography successfully guided radiofrequency catheter ablation to eliminate ventricular tachycardia in a patient with early-stage ARVC.
Supports ablation feasibility in early ARVC; leaves open need for prospective validation of voltage mapping guidance.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a family inherited cardiomyopathy associated with ventricular arrhythmias. With the development of molecular biology, histology, imaging, and other diagnostic techniques, the diagnosis rate and incidence of ARVC have gradually increased. However, ARVC remains rare in clinical practice. Currently, the diagnosis and management of ARVC is far from satisfactory in clinical practice. In the case report, we described a clinical case of radiofrequency ablation guided by voltage mapping and right ventriculography in the treatment of ARVC with ventricular tachycardia and discussed the relevant literatures.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: